← back to search

Alice C. Wei

Weill Cornell Medicine · US
Area of research
Oncology · Surgery
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Cholangiocarcinoma and Gallbladder Cancer Studies, Hepatocellular Carcinoma Treatment and Prognosis, and Cancer Genomics and Diagnostics.
h-index
44
citations
13,387
works
476
NIH funding
primary concept
Medicine
email

Recent publications

RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
Nature 2025cited by 221position: middledoi
Combined Portal and Hepatic Vein Embolization Produces Greater Hypertrophy than Portal Vein Embolization Alone with Similar Post-Hepatectomy Outcomes and is not Impacted by Hepatic Artery Infusion Chemotherapy
Annals of Surgical Oncology 2025cited by 1position: middledoi
Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors
CA A Cancer Journal for Clinicians 2024cited by 44position: middledoi
Standardizing definitions and terminology of left-sided pancreatic resections through an international Delphi consensus
British journal of surgery 2024cited by 26position: middledoi
Advancing minimally invasive hepato-pancreato-biliary surgery: barriers to adoption and equitable access
Surgical Endoscopy 2024cited by 6position: middledoi
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Hepatology 2023cited by 1,595position: middledoi
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
Nature 2023cited by 1,226position: middledoi
Grading Pancreatic Neuroendocrine Tumors Via Endoscopic Ultrasound-guided Fine Needle Aspiration
Annals of Surgery 2022cited by 29position: middledoi
Recurrence of Hepatocellular Carcinoma After Complete Radiologic Response to Trans-Arterial Embolization: A Retrospective Study on Patterns, Treatments, and Prognoses
Annals of Surgical Oncology 2022cited by 16position: middledoi
Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy
Annals of Surgical Oncology 2022cited by 11position: middledoi
Impact of enhanced recovery protocols after pancreatoduodenectomy: meta-analysis
British journal of surgery 2021cited by 57position: middledoi
Early-Onset Pancreas Cancer: Clinical Descriptors, Genomics, and Outcomes
JNCI Journal of the National Cancer Institute 2021cited by 56position: middledoi
Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial
Annals of Surgical Oncology 2019cited by 27position: firstdoi
Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial
˜The œLancet. Gastroenterology & hepatology 2018cited by 166position: middledoi
In‐hospital opioid consumption, but not pain intensity scores, predicts 6‐month levels of pain catastrophizing following hepatic resection: A trajectory analysis
European Journal of Pain 2018cited by 12position: middledoi
A multi‐institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer
Cancer 2013cited by 179position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

William R. Jarnagin · Weill Cornell Medicine3 papers (2022–2025)Mithat Gönen · Centre de Recherche Épidémiologie et Statistique3 papers (2022–2025)T. Peter Kingham · Weill Cornell Medicine3 papers (2022–2025)Jeffrey A. Drebin · Weill Cornell Medicine3 papers (2022–2025)Michael I. D’Angelica · Weill Cornell Medicine3 papers (2022–2025)Malcolm J. Moore · University Health Network2 papers (2013–2019)Victoria G. Aveson · Cornell University2 papers (2022–2022)Laura A. Dawson · University Health Network2 papers (2013–2023)Vikram Deshpande · Harvard University2 papers (2019–2022)Vinod P. Balachandran · Weill Cornell Medicine2 papers (2022–2022)Eileen M. O’Reilly · Erasmus MC Cancer Institute2 papers (2019–2021)Christopher L. Wolfgang · University Medical Center Hamburg-Eppendorf2 papers (2013–2022)Debra A. Goldman · Miriam Hospital2 papers (2022–2022) · 1 papers (2018–2018)Julie K. Heimbach · Mayo Clinic1 papers (2023–2023)Vatche G. Agopian · California NanoSystems Institute1 papers (2023–2023)Salima Ladak · McMaster University1 papers (2018–2018)Erik Mittra · Oregon Health & Science University1 papers (2024–2024)Karen T. Brown · NewYork–Presbyterian Hospital1 papers (2022–2022) · 1 papers (2022–2022)